Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Samer S Kasbari"'
Autor:
Amy S. Clark, Fangxin Hong, Richard S. Finn, Angela M. DeMichele, Edith P. Mitchell, James Zwiebel, Fernanda I. Arnaldez, Robert J. Gray, Victoria Wang, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Stanley R. Hamilton, Mehmet S. Copur, Samer S. Kasbari, Ravneet Thind, Barbara A. Conley, Carlos L. Arteaga, Peter J. O'Dwyer, Lyndsay N. Harris, Alice P. Chen, Keith T. Flaherty
Publikováno v:
Clinical Cancer Research. 29:1477-1483
Purpose: Cyclin D/CDK4/6 is critical in controlling the G1 to S checkpoint. CCND, the gene encoding cyclin D, is known to be amplified in a variety of solid tumors. Palbociclib is an oral CDK4/6 inhibitor, approved in advanced breast cancer in combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0deaba3a14fb4dcac6730d29e90dbb46
https://doi.org/10.1158/1078-0432.ccr-22-2150
https://doi.org/10.1158/1078-0432.ccr-22-2150
Autor:
Keith T. Flaherty, Alice P. Chen, Lyndsay N. Harris, Peter J. O'Dwyer, Carlos L. Arteaga, Barbara A. Conley, Ravneet Thind, Samer S. Kasbari, Mehmet S. Copur, Stanley R. Hamilton, P. Mickey Williams, David Patton, Larry V. Rubinstein, Lisa M. McShane, Victoria Wang, Robert J. Gray, Fernanda I. Arnaldez, James Zwiebel, Edith P. Mitchell, Angela M. DeMichele, Richard S. Finn, Fangxin Hong, Amy S. Clark
Representativeness of Study Participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e238d00836438710bd3e04e5688eb2
https://doi.org/10.1158/1078-0432.22633064.v1
https://doi.org/10.1158/1078-0432.22633064.v1
Autor:
Keith T. Flaherty, Alice P. Chen, Lyndsay N. Harris, Peter J. O'Dwyer, Carlos L. Arteaga, Barbara A. Conley, Ravneet Thind, Samer S. Kasbari, Mehmet S. Copur, Stanley R. Hamilton, P. Mickey Williams, David Patton, Larry V. Rubinstein, Lisa M. McShane, Victoria Wang, Robert J. Gray, Fernanda I. Arnaldez, James Zwiebel, Edith P. Mitchell, Angela M. DeMichele, Richard S. Finn, Fangxin Hong, Amy S. Clark
Purpose:Cyclin D/CDK4/6 is critical in controlling the G1 to S checkpoint. CCND, the gene encoding cyclin D, is known to be amplified in a variety of solid tumors. Palbociclib is an oral CDK4/6 inhibitor, approved in advanced breast cancer in combina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc2562eea6433e82a479a4864ae9520a
https://doi.org/10.1158/1078-0432.c.6533050.v1
https://doi.org/10.1158/1078-0432.c.6533050.v1
Publikováno v:
Neurological Complications of Systemic Cancer and Antineoplastic Therapy ISBN: 9780429120992
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e1c9c7f954953eb982450b36568c3c
https://doi.org/10.1016/b978-0-12-821976-8.00001-3
https://doi.org/10.1016/b978-0-12-821976-8.00001-3
Autor:
Ray McDermott, Samer S. Kasbari, George Hosni Yacoub, William C. Zamboni, William Grogan, Anastasia Ivanova, Bassel F. El-Rayes, Theresa Ryan, Olugbenga Olowokure, Allen Lee Cohn, Dominic T. Moore, Bert H. O'Neil, Tanios Bekaii-Saab, Seamus O'Reilly, Nishan H. Fernando, John McCaffrey, Richard D. Kim, Hanna K. Sanoff, Richard M. Goldberg, Anne M. Horgan, Gregory D. Leonard, Gary Bradley Sherrill
Publikováno v:
Cancer. 124:3118-3126
Background Regorafenib, a multikinase inhibitor that inhibits angiogenesis, growth, and proliferation, prolongs survival as monotherapy in patients with refractory colorectal cancer. This international, double-blind, placebo-controlled, multicenter t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7520857406be1ea65c78e99468c0aeda
https://doi.org/10.1002/cncr.31552
https://doi.org/10.1002/cncr.31552
Autor:
Heather A. Wakelee, Charles Butts, Jyoti D. Patel, Tracey L. Evans, Sean R McDermott, William Tester, Jan M. Rothman, Stephen L. Graziano, Suresh S. Ramalingam, Andrew E. Chapman, Mark D. Sborov, Samer S Kasbari, Joan H. Schiller, Alex A. Adjei, Seena C. Aisner, Suzanne E. Dahlberg, Atif Shafqat, Steven M. Keller, Anne M. Traynor, David R. Gandara, Natasha B. Leighl, Roman Perez-Soler, Leora Horn
Publikováno v:
The Lancet. Oncology
Summary Background Adjuvant chemotherapy for resected early-stage non-small-cell lung cancer (NSCLC) provides a modest survival benefit. Bevacizumab, a monoclonal antibody directed against VEGF, improves outcomes when added to platinum-based chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::707691534dca9d63a0be49762455a685
http://europepmc.org/articles/PMC5789803
http://europepmc.org/articles/PMC5789803
Autor:
Kleckner IR; Department of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, 265 Crittenden Blvd., Box CU 420658, Rochester, NY, 14642, USA. Ian_Kleckner@URMC.Rochester.edu.; Department of Neuroscience, University of Rochester, Rochester, NY, USA. Ian_Kleckner@URMC.Rochester.edu., Jusko TA; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA., Culakova E; Department of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, 265 Crittenden Blvd., Box CU 420658, Rochester, NY, 14642, USA., Chung K; Department of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, 265 Crittenden Blvd., Box CU 420658, Rochester, NY, 14642, USA., Kleckner AS; Department of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, 265 Crittenden Blvd., Box CU 420658, Rochester, NY, 14642, USA., Asare M; Department of Public Health, Baylor University, Waco, TX, USA., Inglis JE; Department of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, 265 Crittenden Blvd., Box CU 420658, Rochester, NY, 14642, USA., Loh KP; Division of Hematology/Oncology, Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Peppone LJ; Department of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, 265 Crittenden Blvd., Box CU 420658, Rochester, NY, 14642, USA., Miller J; Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Melnik M; Cancer Research Consortium of West Michigan NCORP, Grand Rapids, MI, USA., Kasbari S; Southeast Clinical Oncology Research Consortium (SCOR), Winston Salem, NC, USA., Ossip D; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA., Mustian KM; Department of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, 265 Crittenden Blvd., Box CU 420658, Rochester, NY, 14642, USA.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Sep; Vol. 189 (2), pp. 521-532. Date of Electronic Publication: 2021 Jun 30.
Autor:
Waterhouse DM; The US Oncology Network/Oncology Hematology Care, Cincinnati, OH., Garon EB; David Geffen School of Medicine at UCLA/Translational Research in Oncology-US Network, Los Angeles, CA., Chandler J; West Cancer Center, Memphis, TN., McCleod M; Sarah Cannon Research Institute/Florida Cancer Specialists, Cape Coral, FL., Hussein M; Sarah Cannon Research Institute/Florida Cancer Specialists, The Villages, FL., Jotte R; The US Oncology Network/Rocky Mountain Cancer Centers, Denver, CO., Horn L; Vanderbilt University Medical Center, Nashville, TN., Daniel DB; Sarah Cannon Research Institute/Tennessee Oncology, Chattanooga, TN., Keogh G; Charleston Oncology, Charleston, SC., Creelan B; Moffitt Cancer Center, Tampa, FL., Einhorn LH; Simon Cancer Center, Indiana University, Indianapolis, IN., Baker J; Jackson Oncology Associates, Jackson, MS., Kasbari S; Southeastern Medical Oncology Center, Goldsboro, NC., Nikolinakos P; Hematology and Medical Oncology, University Cancer and Blood Center, LLC, Athens, GA., Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN., Couture F; CISSS Chaudiéere-Appalaches, Levis, Quebec, Canada., Leighl NB; Department of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Reynolds C; Sarah Cannon Research Institute/Florida Cancer Specialists, Ocala, FL., Blumenschein G Jr; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Gunuganti V; Texas Oncology, San Antonio, TX., Li A; Bristol Myers Squibb Company, Princeton, NJ., Aanur N; Bristol Myers Squibb Company, Princeton, NJ., Spigel DR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 20; Vol. 38 (33), pp. 3863-3873. Date of Electronic Publication: 2020 Sep 10.